Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.
Exelon Corp.
EXCUtilitiesGenerated Jul 5, 2026, 08:11 PM UTC
EXC (Exelon Corp.) analytical snapshot. Revenue grew +13.9% YoY to $21.73B. 5-year revenue CAGR -8.8%; 10y CAGR -2.6%. Net margin at 0.00% (contracting ▼). Market cap $48.99B at $47.88 per share. Trailing P/E 15.91, P/S 2.25, P/B 1.67. EV/Operating income ≈ 24.29 (EV $97.71B). Risk: Elevated. Macro: Risk-on · Supportive. Composite analytical score -3 (data confidence 82%). Descriptive analytics from public filings — not investment advice.
Free SEC analysis
— computed from SEC filings, free to readFundamentals
Revenue grew +13.9% YoY to $21.73B. 5-year revenue CAGR -8.8%; 10y CAGR -2.6%. Net margin at 0.00% (contracting ▼).
- Revenue grew +13.9% YoY to $21.73B.
- 5-year revenue CAGR -8.8%; 10y CAGR -2.6%.
- Net margin at 0.00% (contracting ▼).
- Return on equity 0.00%, ROA 0.00%, ROIC 5.27%.
- Gross margin 0.00%, operating margin 18.52%.
- Free cash flow margin -12.45% (-$2.71B).
- Debt/equity 1.69, current ratio 0.94, net debt $48.72B.
- Asset turnover 0.18 — capital efficiency.
| FY | Revenue | Rev YoY | Gross% | Op% | Net% | FCF | ROE% |
|---|---|---|---|---|---|---|---|
| 2016 | $27.43B | — | 0.00 | 11.29 | 0.00 | -$1.62B | 0.00 |
| 2017 | $29.45B | +7.4% | 0.00 | 14.97 | 0.00 | -$8.0M | 0.00 |
| 2018 | $31.37B | +6.5% | 0.00 | 10.24 | 0.00 | -$92.0M | 0.00 |
| 2019 | $33.56B | +7.0% | 0.00 | 13.08 | 0.00 | -$104.0M | 0.00 |
| 2020 | $35.98B | +7.2% | 0.00 | 10.81 | 0.00 | $1.05B | 0.00 |
| 2021 | $34.44B | -4.3% | 0.00 | 12.70 | 0.00 | -$589.0M | 0.00 |
| 2022 | $16.66B | -51.6% | 0.00 | 13.15 | 0.00 | -$3.81B | 0.00 |
| 2023 | $17.94B | +7.7% | 0.00 | 14.95 | 0.00 | -$4.97B | 0.00 |
| 2024 | $19.08B | +6.4% | 0.00 | 17.38 | 0.00 | -$2.28B | 0.00 |
| 2025 | $21.73B | +13.9% | 0.00 | 18.52 | 0.00 | -$2.71B | 0.00 |
| Quarter end | Revenue | YoY | QoQ | Net margin |
|---|---|---|---|---|
| Mar 31, 2025 | $6.71B | +11.1% | — | — |
| Jun 30, 2025 | $12.14B | +6.5% | +80.8% | — |
| Jun 30, 2025 | $5.43B | -52.4% | -55.3% | — |
| Sep 30, 2025 | $18.85B | +7.3% | +247.3% | — |
| Sep 30, 2025 | $6.71B | -61.8% | -64.4% | — |
| Mar 31, 2026 | $7.24B | +7.9% | +8.0% | — |
Filings & Ownership
Latest annual report (10-K) filed Feb 12, 2026. Latest quarterly report (10-Q) filed May 6, 2026. 17 recent 8-K material-event filings in the index.
- Latest annual report (10-K) filed Feb 12, 2026.
- Latest quarterly report (10-Q) filed May 6, 2026.
- 17 recent 8-K material-event filings in the index.
- Recent insider Form 4s: 0 buy vs 0 sell transactions.
- ~10,000+ recent 13F-HR filings reference Exelon Corp.; broad institutional reporting.
- Recent filers include SPHINX TRADING, LP, SPHINX TRADING, LP, Crow Point Partners, LLC.
- 20 recent 13G passive institutional ownership notices.
| Filer | Form | Filed |
|---|---|---|
| SPHINX TRADING, LP | 13F-HR | Feb 6, 2015 |
| SPHINX TRADING, LP | 13F-HR | Feb 9, 2015 |
| Crow Point Partners, LLC | 13F-HR | Feb 10, 2009 |
| Allen Investment Management LLC | 13F-HR | Feb 14, 2007 |
| MARK MORRIS ET AL | 13F-HR | Aug 13, 2008 |
| Date | Form | Description |
|---|---|---|
| May 6, 2026 | 8-K | 8-K |
| Apr 30, 2026 | 8-K | 8-K |
| Apr 16, 2026 | 8-K | 8-K |
| Feb 20, 2026 | 8-K | 8-K |
| Feb 12, 2026 | 8-K | 8-K |
| Dec 4, 2025 | 8-K | 8-K |
| Nov 26, 2025 | 8-K | 8-K |
| Nov 24, 2025 | 8-K | 8-K |
SEC Filing Deep-Analysis
2 risk signal(s), 2 positive signal(s), 1 watch item(s) detected from XBRL filing diff analysis. Strong cash conversion (OCF > NI) combined with growing deferred revenue provides high forward visibility. The business model appears to generate sustainable, recurring cash flows — a positive structural indicator.
- Material weakness in internal controls: The term "material weakness" appears in 20 recent filing(s) (vs 2 in the prior period). This risk language is ongoing.
- NEW: Restatement of financial statements in latest filing: The term "restate" "financial statements" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 8 filing(s).
- Operating cash flow exceeds net income: OCF is 1.83x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
- Deferred revenue growing — future revenue visibility: Deferred revenue grew +31.7% to $133.0M, providing forward revenue visibility. This is a positive leading indicator for subscription or contract-based businesses.
- NEW: Off-balance sheet arrangements: Off-balance sheet arrangements appears in recent filings but not in the prior 24-month period. Monitor for materiality.
- Endogenous analysis: Strong cash conversion (OCF > NI) combined with growing deferred revenue provides high forward visibility. The business model appears to generate sustainable, recurring cash flows — a positive structural indicator.
- 2 new XBRL disclosure(s) in latest filing — expanding reporting scope.
- 20 disclosure(s) dropped from prior year — reduced reporting granularity.
- 2 new risk-language term(s) detected in filing text: Restatement of financial statements, Off-balance sheet arrangements.
- Ongoing high-severity risk language: Material weakness in internal controls.
| Metric | Prior year | Latest year | Change | % Change |
|---|---|---|---|---|
| Revenue | $19.08B | $21.73B | $2.65B | +13.9% |
| Operating income | $3.31B | $4.02B | $708.0M | +21.4% |
| Net income | $2.71B | $2.56B | $-144.0M | -5.3% |
| Operating cash flow | $4.87B | $4.70B | $-167.0M | -3.4% |
| Capex | $7.15B | $7.41B | $261.0M | +3.7% |
| Total assets | $101.86B | $107.78B | $5.93B | +5.8% |
| Total liabilities | $76.10B | $80.86B | $4.76B | +6.3% |
| Long-term debt | $44.67B | $49.43B | $4.76B | +10.7% |
| Cash & equivalents | $672.0M | $407.0M | $-265.0M | -39.4% |
| Stockholders equity | $25.75B | $26.92B | $1.17B | +4.5% |
| Accounts receivable | $2.34B | $2.74B | $396.0M | +16.9% |
| Interest expense | $1.52B | $1.53B | $5.0M | +0.3% |
| Type | Concepts |
|---|---|
| Added | EffectiveIncomeTaxRateReconciliationNondeductibleExpense, IncomeTaxReconciliationNondeductibleExpense |
| Removed | AccumulatedDeferredInvestmentTaxCredit, CurrentFederalTaxExpenseBenefit, CurrentStateAndLocalTaxExpenseBenefit, DebtInstrumentCarryingAmount, DebtInstrumentFairValue, DebtInstrumentUnamortizedDiscountPremiumNet, DeferredFederalIncomeTaxExpenseBenefit, DeferredIncomeTaxLiabilities, DeferredStateAndLocalIncomeTaxExpenseBenefit, DeferredTaxAssetsDerivativeInstruments |
| Term | Severity | Recent | Prior | Status |
|---|---|---|---|---|
| Material weakness in internal controls | high | 20 | 2 | Ongoing |
| Restatement of financial statements | high | 8 | 0 | NEW |
| Impairment charge | medium | 65 | 3 | Ongoing |
| Restructuring | medium | 142 | 2 | Ongoing |
| Off-balance sheet arrangements | medium | 84 | 0 | NEW |
| Related party transactions | low | 116 | 8 | Ongoing |
Unlock the rest
- ProValuationMarket cap $48.99B at $47.88 per share.
- ProPrice & TechnicalsPrice $47.88 — uptrend (above 200-DMA); 1-month momentum positive.
- ProMacro & RatesMarket regime: Risk-on · Supportive.
- ProRisk ScorecardComposite risk: Elevated.
This content is for Pro subscribers
Unlock the full breakdown from all analysts — valuation (DCF & Graham), price & technicals, macro, risk scorecard, and 13F/13D ownership flow — plus your research workspace.
3 sections free · 4 Pro sections locked · composite -3
Macro exposure
Rate-sensitive · High sensitivityMacro regime: Risk-on · Supportive. Exelon Corp. is a rate-sensitive name (high macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.
Analytical read
deterministic previewPrice $47.88 — uptrend (above 200-DMA); 1-month momentum positive..
Peer comparison
Rate-sensitive groupHow EXC stacks up against tracked peers with similar macro sensitivity — by analytical score and macro exposure.
| Company | Score | Macro |
|---|---|---|
| Chubb Ltd. CB | 23 | Neutral |
| U.S. Bancorp USB | 17 | Neutral |
| Prologis Inc. PLD | 14 | Neutral |
| JPMorgan Chase & Co. JPM | 13 | Neutral |
| American Express Co. AXP | 11 | Neutral |
| Bank of America Corp. BAC | 11 | Neutral |
| Visa Inc. V | 8 | Neutral |
| Mastercard Inc. MA | 8 | Neutral |
| Public Storage PSA | 8 | Neutral |
| Dominion Energy D | 6 | Neutral |
| Charles Schwab Corp. SCHW | 6 | Neutral |
| PNC Financial Services PNC | 4 | Neutral |
| Realty Income Corp. O | 4 | Neutral |
| Travelers Cos. TRV | 2 | Neutral |
| NextEra Energy NEE | 0 | Neutral |
| Duke Energy Corp. DUK | 0 | Neutral |
| Bank of New York Mellon BK | 0 | Neutral |
| Wells Fargo & Co. WFC | -1 | Neutral |
| Welltower Inc. WELL | -1 | Neutral |
| Exelon Corp. EXC● you | -3 | Neutral |
| Digital Realty Trust DLR | -6 | Neutral |
| Allstate Corp. ALL | -7 | Neutral |
| S&P Global SPGI | -8 | Neutral |
| American Water Works AWK | -9 | Neutral |
| Goldman Sachs Group GS | -10 | Neutral |
| Citigroup Inc. C | -11 | Neutral |
| Morgan Stanley MS | -13 | Neutral |
| MetLife Inc. MET | -13 | Neutral |
| BlackRock Inc. BLK | -15 | Neutral |
| American Electric Power AEP | -18 | Neutral |
| Crown Castle Inc. CCI | -18 | Neutral |
| American Tower Corp. AMT | -35 | Neutral |
| Moody's Corp. MCO | — | Neutral |
| American International Group AIG | — | Neutral |
| Southern Company SO | — | Neutral |
| Equinix Inc. EQIX | — | Neutral |
| Simon Property Group SPG | — | Neutral |
| Truist Financial TFC | — | Neutral |
| Capital One Financial COF | — | Neutral |
| Marsh & McLennan MMC | — | Neutral |
| CME Group Inc. CME | — | Neutral |
| Xcel Energy XEL | — | Neutral |
| Equity Residential EQR | — | Neutral |